Labeled for this condition
Medicines for parkinson's disease
19 medicines have an FDA label indicated for parkinson's disease; 14 are listed from generic labelers and 0 have a presentation in shortage now (FDA files, October 8, 2026).
Which medicines are labeled for parkinson's disease?
Each label names the condition in its indications; the record shows the label's words. A list of labeled medicines is not a treatment plan.
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Ropinirole | none listed | 26 labelers | $0.046 per tablet 0.25 mg tablet | No | No current entry | 13 |
| Pramipexole | none listed | 22 labelers | $0.0452 per tablet 0.25 mg tablet | No | No current entry | 16 |
| Carbidopa and levodopa | Rytary, Crexont, Sinemet | 33 labelers | $0.0759 per tablet 25-100 tablet | No | No current entry | 5 |
| Amantadine | Gocovri | 34 labelers | $0.143 per capsule 100 mg capsule | No | No current entry | 6 |
| Benztropine | none listed | 23 labelers | $0.0753 per tablet 1 mg tablet | No | A presentation being discontinued | 3 |
| Rasagiline | Azilect | 14 labelers | $0.521 per tablet 0.5 mg tablet | No | No current entry | 3 |
| Carbidopa and entacapone and levodopa | none listed | 4 labelers | $0.695 per tablet 25-100-200 mg tablet | No | No current entry | 1 |
| Selegiline | Emsam, Zelapar | 11 labelers | $0.756 per capsule 5 mg capsule | No | No current entry | 1 |
| Trihexyphenidyl | none listed | 8 labelers | $0.0884 per tablet 2 mg tablet | No | No current entry | 1 |
| Entacapone | none listed | 11 labelers | $0.325 per tablet 200 mg tablet | No | No current entry | 1 |
| Bromocriptine | Cycloset | 6 labelers | $1.61 per tablet 2.5 mg tablet | No | No current entry | 5 |
| Carbidopa | Lodosyn | 7 labelers | $0.536 per tablet 25 mg tablet | No | No current entry | 0 |
| Levodopa | Inbrija | none listed | n/a | No | No current entry | 0 |
| Rotigotine | Neupro | none listed | $28.29 per patch 1 mg/24 hr patch | No | No current entry | 0 |
| Apomorphine | Onapgo, Apokyn | 1 labeler | n/a | No | No current entry | 0 |
| Tolcapone | Tasmar | 1 labeler | n/a | Yes | No current entry | 0 |
| Istradefylline | Nourianz | none listed | n/a | No | No current entry | 0 |
| Opicapone | Ongentys | none listed | $24.67 per capsule 25 mg capsule | No | No current entry | 0 |
| Foscarbidopa and foslevodopa | Vyalev | none listed | n/a | No | No current entry | 0 |
Source: FDA drug labels (indications) via openFDA; NDC Directory; CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)
What do pharmacies pay?
Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price